Stock analysis, trade plans, and proprietary indicators by Trend Edge.
About Vanda Pharmaceuticals Inc
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs worldwide. The company's commercial portfolio includes Fanapt for the acute treatment of manic or mixed episodes associated with bipolar I disorder and the treatment of schizophrenia; HETLIOZ to treat non-24-hour sleep-wake disorders and nighttime sleep disturbances; PONVORY to treat relapsing … Read full Trend Edge analysis →
Sector: Healthcare
Industry: Biotechnology
Exchange: NASDAQ
IPO Date: April 12, 2006
Headquarters: 2200 Pennsylvania Avenue NW, Washington, DC, United States, 20037
Founder-Led: Yes — Mihael H. Polymeropoulos (Founder, President, Chief Executive Officer & Chairman of the Board)
Key Metrics
Current Price
$6.46
Market Cap
$373M
Float
53.8M
Shares Outstanding
60.1M
P/E (Forward)
103.09
Price/Sales (TTM)
1.71
vs. Analyst Target
+130.7% to analyst PT
Profit Margin
-109.99%
Operating Margin (TTM)
-97.11%
Revenue (TTM)
$218M
Earnings Growth (YoY)
-95.90%
Dividend Rate
None
Analyst Target Price
$14.90 (3 analysts)
Financial History
Annual Revenue & Earnings History
Year
Revenue
Net Income
Gross Profit
EBITDA
2020
$248M
$23.3M
$225M
$34.5M
2021
$269M
$33.2M
$243M
$45.0M
2022
$254M
$6.3M
$230M
$9.1M
2023
$193M
$2.5M
$193M
-$14.0M
2024
$199M
-$18.9M
$187M
-$32.5M
2025
$216M
-$220M
$203M
-$139M
Recent Quarterly Revenue & Net Income
Quarter
Revenue
Net Income
Jun 2025
$52.6M
-$27.2M
Sep 2025
$56.3M
-$22.6M
Dec 2025
$57.2M
-$141M
Mar 2026
$51.7M
-$48.6M
Ownership & Float
Insider Ownership
6.1%
Institutional Ownership
78.7%
Short Float
11.5%
% of All Funds Holding
1.86%
Number of Funds Holding
153
Current Moving Averages
Trend Edge tracks near-term, medium-term, cyclical, and secular moving averages across weekly and monthly timeframes to identify trend structure at every horizon.
Timeframe
SMA
Value
Trend Context
Weekly
10-Week SMA
$6.75
Near-term / short-term trend
Weekly
40-Week SMA
$6.30
Medium-term trend
Weekly
80-Week SMA
$5.44
Cyclical trend (business cycle)
Weekly
200-Week SMA
$5.87
Secular trend (multi-year)
Monthly
10-Month SMA
$6.52
Near-term monthly trend
Monthly
20-Month SMA
$5.57
Medium-term monthly trend
Monthly
40-Month SMA
$5.36
Secular monthly trend
Volume Shelves — Support & Resistance
Trend Edge identifies volume shelves: price zones where historically elevated trading volume
creates structural support or resistance. A volume shelf forms when a disproportionate share of cumulative
volume was transacted at a specific price level, making it a high-conviction anchor for future price reactions.
Price Level
Type
Volume Ratio
Age
$8.60
resistance
1.58x
1 months ago
$5.40
support
3.42x
4 months ago
$4.50
support
1.40x
5 months ago
Historical Earnings Reactions (81 events)
Timeframe
Avg Return
Median
Win Rate
Best
Worst
Gap
0.30%
0.00%
48.15%
24.50%
-15.61%
1 Day
0.00%
-0.37%
46.91%
26.83%
-21.94%
1 Week
10.28%
-1.01%
44.44%
676.24%
-24.37%
2 Weeks
15.18%
0.60%
53.09%
1031.68%
-20.06%
1 Month
19.71%
1.79%
51.25%
1210.89%
-42.56%
Next earnings: July 25, 2026 (58 days away)
Seasonality & Day-of-Week Patterns
Monthly Seasonality
Month
Avg Return
Win Rate
Samples
Jan
-3.2%
45.0%
20
Feb
0.2%
50.0%
20
Mar
-2.9%
40.0%
20
Apr
-1.1%
45.0%
20
May
71.8%
45.0%
20
Jun
4.8%
60.0%
20
Jul
-3.3%
40.0%
20
Aug
-0.3%
45.0%
20
Sep
-4.8%
30.0%
20
Oct
-1.2%
45.0%
20
Nov
5.4%
65.0%
20
Dec
5.2%
55.0%
20
Day-of-Week Tendencies
Day
Avg Return
Win Rate
Samples
Monday
-0.08%
46.0%
949
Tuesday
0.04%
45.1%
1039
Wednesday
0.26%
48.2%
1038
Thursday
0.63%
47.0%
1019
Friday
-0.03%
46.4%
1015
Top Institutional Holders
Institutional holder breakdown coming soon.
Total institutional ownership: 78.7%
Insider Transactions — Smart Summary
Total insider ownership: 6.1%
Founder-led management: Mihael H. Polymeropoulos (Founder, President, Chief Executive Officer & Chairman of the Board)
Trend Edge's AI Consult feature delivers a comprehensive, multi-layer trade plan for Vanda Pharmaceuticals Inc
(VNDA) powered by Claude Opus — Anthropic's most capable AI model.
The analysis covers five layers:
technical analysis (near-term, medium-term, cyclical, and secular trend, momentum,
volume shelf support and resistance, breakout and breakdown signals),
qualitative analysis (business model, competitive moat, sector dynamics),
insider sentiment (buy and sell signals from executive and director transactions),
share stats analysis (institutional accumulation, fund positioning, short float squeeze potential), and
fundamental analysis (valuation, revenue growth, profit margin, earnings quality).
AI Consult synthesizes all five layers into a single bullish or bearish thesis with explicit entry, exit,
stop loss, and take profit levels — giving you a complete, AI-powered trade plan with defined risk/reward.
Whether you are building a long position, initiating a short, or looking for a reversal setup,
AI Consult identifies the highest-probability signal from the current trend.